CSPC PHARMA (01093) announced the financial results of CSPC Innovation Pharmaceutical (300765.SZ) for the first three quarters. The group recorded revenue of RMB1.593 billion, a year-on-year increase of 7.71%. However, it reported a net loss attributable to shareholders of RMB24.05 million, with a basic loss per share of RMB0.0173.